NEW YORK, Feb. 20, 2018 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Johnson & Johnson ("Johnson & Johnson") (NYSE:JNJ) between February 22, 2013 and February 7, 2018. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the District of New Jersey. To get more information go to:
http://www.zlk.com/pslra-d/johnson-johnson?wire=3
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) Johnson & Johnson has known for decades that its talc products include asbestos fibers and that the exposure to those fibers can cause ovarian cancer and mesothelioma; and (2) as a result, Defendants' public statements were materially false and misleading at all relevant times.
If you suffered a loss in Johnson & Johnson you have until April 9, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com


Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Goldman Sachs Sees US Stock Buybacks Outpacing Equity Issuance as AI Funding Rises
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
DeepSeek to Raise AI API Prices as Demand for New Models Surges
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users
Treasury Wine Estates Shares Jump as U.S. Overhaul Lifts FY2026 Outlook
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
Apple Tests China’s CXMT Memory Chips for iPhones and MacBooks Amid AI Supply Crunch
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook 



